M. P. BISHOP

480 total citations
25 papers, 342 citations indexed

About

M. P. BISHOP is a scholar working on Psychiatry and Mental health, Organic Chemistry and Pharmacology. According to data from OpenAlex, M. P. BISHOP has authored 25 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 4 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in M. P. BISHOP's work include Schizophrenia research and treatment (9 papers), Epilepsy research and treatment (6 papers) and Synthesis and Reactivity of Heterocycles (3 papers). M. P. BISHOP is often cited by papers focused on Schizophrenia research and treatment (9 papers), Epilepsy research and treatment (6 papers) and Synthesis and Reactivity of Heterocycles (3 papers). M. P. BISHOP collaborates with scholars based in United States and United Kingdom. M. P. BISHOP's co-authors include Donald M. Gallant, Robert G. Heath, S. Thomas Elder, R Guerrero-Figueroa, Gary C. Galbraith, Colin G. Edwards, R E Phillips, George M. Simpson, J. P. PRATT and R. Thompson and has published in prestigious journals such as Science, American Journal of Psychiatry and Environmental Health Perspectives.

In The Last Decade

M. P. BISHOP

23 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. P. BISHOP United States	10	192	75	74	49	39	25	342
D Bente Germany	10	165 0.9×	102 1.4×	94 1.3×	22 0.4×	65 1.7×	58	387
Abraham Flemenbaum United States	12	254 1.3×	118 1.6×	61 0.8×	31 0.6×	49 1.3×	33	430
WilliamE. Bunney United States	8	141 0.7×	92 1.2×	30 0.4×	89 1.8×	47 1.2×	9	329
DennisL Murphy United States	10	160 0.8×	140 1.9×	38 0.5×	87 1.8×	68 1.7×	12	474
Neil M. Kurtz United States	11	189 1.0×	71 0.9×	46 0.6×	34 0.7×	74 1.9×	18	393
Harold Landis United States	8	97 0.5×	133 1.8×	59 0.8×	28 0.6×	88 2.3×	10	355
J Delay France	7	135 0.7×	77 1.0×	32 0.4×	49 1.0×	56 1.4×	20	309
van Kammen Dp United States	12	201 1.0×	141 1.9×	55 0.7×	15 0.3×	41 1.1×	19	407
Joseph E. Comaty United States	13	177 0.9×	98 1.3×	37 0.5×	37 0.8×	46 1.2×	28	430
R Guerrero-Figueroa United States	12	167 0.9×	206 2.7×	147 2.0×	39 0.8×	32 0.8×	42	395

Countries citing papers authored by M. P. BISHOP

Since Specialization

Citations

This map shows the geographic impact of M. P. BISHOP's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. BISHOP with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. BISHOP more than expected).

Fields of papers citing papers by M. P. BISHOP

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. BISHOP. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. BISHOP. The network helps show where M. P. BISHOP may publish in the future.

Co-authorship network of co-authors of M. P. BISHOP

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. BISHOP. A scholar is included among the top collaborators of M. P. BISHOP based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. BISHOP. M. P. BISHOP is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

BISHOP, M. P., et al.. (1986). Pulmonary function analysis in the rabbit following bronchochallenge to causative agents and mediators of the acute byssinotic response.. Environmental Health Perspectives. 66. 61–71.

BISHOP, M. P., et al.. (1977). Efficacy of loxapine in the treatment of paranoid schizophrenia. Psychopharmacology. 51(2). 107–115. 16 indexed citations

Guerrero-Figueroa, R, et al.. (1970). Electrographic and behavioral effects of diazepam during alcohol withdrawal stage in cats. Neuropharmacology. 9(2). 143–150. 25 indexed citations

Gallant, Donald M., et al.. (1969). Doxepin Versus Diazepam: A Controlled Evaluation in 100 Chronic Alcoholic Patients. PubMed. 9(1). 57–65. 20 indexed citations

Gallant, Donald M. & M. P. BISHOP. (1969). AHR-1900: a butyrophenone derivative.. PubMed. 11(12). 793–5. 2 indexed citations

BISHOP, M. P., Donald M. Gallant, & R. Thompson. (1968). A Preliminary Evaluation of Magnesium Pemoline in Chronic Schizophrenic Patients. American Journal of Psychiatry. 124(7). 982–986. 2 indexed citations

Gallant, Donald M. & M. P. BISHOP. (1968). Lenperone: a controlled evaluation in chronic schizophrenic patients.. PubMed. 10(5). 441–40. 30 indexed citations

BISHOP, M. P. & Donald M. Gallant. (1967). A Controlled Study of SK&F 14336 in Acute Schizophrenia. PubMed. 7(6). 342–347. 1 indexed citations

Scrignar, C.B., et al.. (1967). A controlled evaluation of butaperazine in the neurotic anxiety syndrome.. PubMed. 9(9). 492–5. 1 indexed citations

10.

Gallant, Donald M., et al.. (1966). A Preliminary Evaluation of P-4657B: A Thioxanthene Derivative. American Journal of Psychiatry. 123(3). 345–346. 15 indexed citations

11.

BISHOP, M. P.. (1966). Observations of Placebo Response in Chronic Schizophrenic Patients. Archives of General Psychiatry. 14(5). 497–497. 15 indexed citations

12.

Gallant, Donald M., et al.. (1965). TPS-23: A NEW THIORIDAZINE DERIVATIVE.. PubMed. 7. 102–4. 9 indexed citations

13.

Gallant, Donald M., et al.. (1965). A DOUBLE-BLIND COMPARISON OF WY-3498, DIAZEPAM AND PLACEBO IN PSYCHIATRIC OUTPATIENTS. American Journal of Psychiatry. 121(8). 809–811. 7 indexed citations

14.

BISHOP, M. P.. (1965). Extrapyramidal Side Effects and Therapeutic Response. Archives of General Psychiatry. 13(2). 155–155. 34 indexed citations

15.

Gallant, Donald M., et al.. (1965). Further observations on trifluperidol: a butyrophenone derivative. Psychopharmacology. 7(1). 37–43. 4 indexed citations

16.

Gallant, Donald M., Colin G. Edwards, M. P. BISHOP, & Gary C. Galbraith. (1964). WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS. American Journal of Psychiatry. 121(5). 491–493. 34 indexed citations

17.

Gallant, Donald M., et al.. (1963). TRIFLUPERIDOL: A BUTYROPHENONE DERIVATIVE. American Journal of Psychiatry. 120(5). 485–487. 5 indexed citations

18.

BISHOP, M. P. & Donald M. Gallant. (1963). BEHAVIORAL TOXICITY ASSOCIATED WITH BENZQUINAMIDE (QUANTRIL) THERAPY IN SCHIZOPHRENIC PATIENTS. American Journal of Psychiatry. 120(2). 180–181. 4 indexed citations

19.

BISHOP, M. P., S. Thomas Elder, & Robert G. Heath. (1963). Intracranial Self-Stimulation in Man. Science. 140(3565). 394–396. 87 indexed citations

20.

Gallant, Donald M., et al.. (1963). THE RELATIONSHIP BETWEEN SEROTONIN ANTAGONISM AND TRANQUILIZING ACTIVITY. American Journal of Psychiatry. 119(9). 882–882. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact